These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Polygraphic, clinical and therapeutic markers of dopamine-dependent depressions]. Mouret J; Lemoine P; Minuit MP C R Acad Sci III; 1987; 305(8):301-6. PubMed ID: 3115502 [TBL] [Abstract][Full Text] [Related]
25. [The treatment of diabetic arteritis of the lower limbs by Trivastal]. Journ Annu Diabetol Hotel Dieu; 1972; 13(0):326-31. PubMed ID: 4679620 [No Abstract] [Full Text] [Related]
36. Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation. Smith LA; Tel BC; Jackson MJ; Hansard MJ; Braceras R; Bonhomme C; Chezaubernard C; Del Signore S; Rose S; Jenner P Mov Disord; 2002 Sep; 17(5):887-901. PubMed ID: 12360537 [TBL] [Abstract][Full Text] [Related]
37. Treatment of memory impairment, vertigo and tinnitus in the elderly with piribedil in an Indian general practice setting. Hastak SM J Indian Med Assoc; 2003 Aug; 101(8):500-1. PubMed ID: 15071809 [TBL] [Abstract][Full Text] [Related]
38. End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study. Simon N; Micallef J; Reynier JC; Lesourd M; Witjas T; Alicherif A; Azulay JP; Blin O Mov Disord; 2005 Jul; 20(7):803-9. PubMed ID: 15726579 [TBL] [Abstract][Full Text] [Related]